| RECORD |
SYMBOL |
NAME |
PRIORITY |
|
1
|
A2M
|
alpha-2-macroglobulin
|
3
|
|
2
|
AANAT
|
arylalkylamine N-acetyltransferase
|
2
|
|
3
|
ABCA1
|
ATP-binding cassette, sub-family A (ABC1), member 1
|
1
|
|
4
|
ABCA2
|
ATP-binding cassette, sub-family A (ABC1), member 2
|
2
|
|
5
|
ABCA4
|
ATP-binding cassette, sub-family A (ABC1), member 4
|
2
|
|
6
|
ABCA7
|
ATP-binding cassette, sub-family A (ABC1), member 7
|
1
|
|
7
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
2
|
|
8
|
ABCB11
|
ATP-binding cassette, sub-family B (MDR/TAP), member 11
|
2
|
|
9
|
ABCB4
|
ATP-binding cassette, sub-family B (MDR/TAP), member 4
|
2
|
|
10
|
ABCC1
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
|
2
|
|
11
|
ABCC2
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 2
|
2
|
|
12
|
ABCC3
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 3
|
2
|
|
13
|
ABCC4
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 4
|
2
|
|
14
|
ABCC5
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 5
|
2
|
|
15
|
ABCC6
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 6
|
3
|
|
16
|
ABCC8
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8
|
2
|
|
17
|
ABCC9
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 9
|
2
|
|
18
|
ABCD1
|
ATP-binding cassette, sub-family D (ALD), member 1
|
2
|
|
19
|
ABCD2
|
ATP-binding cassette, sub-family D (ALD), member 2
|
2
|
|
20
|
ABCD3
|
ATP-binding cassette, sub-family D (ALD), member 3
|
2
|
|
21
|
ABCG1
|
ATP-binding cassette, sub-family G (WHITE), member 1
|
1
|
|
22
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2
|
2
|
|
23
|
ABCG4
|
ATP-binding cassette, sub-family G (WHITE), member 4
|
1
|
|
24
|
ABCG5
|
ATP-binding cassette, sub-family G (WHITE), member 5 (sterolin 1)
|
1
|
|
25
|
ABCG8
|
ATP-binding cassette, sub-family G (WHITE), member 8 (sterolin 2)
|
2
|
|
26
|
ABL2
|
v-abl Abelson murine leukemia viral oncogene homolog 2 (arg, Abelson-related gene)
|
2
|
|
27
|
ABO
|
ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)
|
2
|
|
28
|
ACACA
|
acetyl-Coenzyme A carboxylase alpha
|
3
|
|
29
|
ACADL
|
acyl-Coenzyme A dehydrogenase, long chain
|
2
|
|
30
|
ACADM
|
acyl-Coenzyme A dehydrogenase, C-4 to C-12 straight chain
|
2
|
|
31
|
ACADS
|
acyl-Coenzyme A dehydrogenase, C-2 to C-3 short chain
|
2
|
|
32
|
ACADVL
|
acyl-Coenzyme A dehydrogenase, very long chain
|
2
|
|
33
|
ACAN
|
aggrecan
|
2
|
|
34
|
ACAT1
|
acetyl-Coenzyme A acetyltransferase 1 (acetoacetyl Coenzyme A thiolase)
|
1
|
|
35
|
ACAT2
|
acetyl-Coenzyme A acetyltransferase 2 (acetoacetyl Coenzyme A thiolase)
|
1
|
|
36
|
ACE
|
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1
|
1
|
|
37
|
ACE2
|
angiotensin I converting enzyme (peptidyl-dipeptidase A) 2
|
1
|
|
38
|
ACHE
|
acetylcholinesterase (Yt blood group)
|
2
|
|
39
|
ACOT11
|
acyl-CoA thioesterase 11
|
2
|
|
40
|
ACOT12
|
acyl-CoA thioesterase 12
|
2
|
|
41
|
ACP1
|
acid phosphatase 1, soluble
|
2
|
|
42
|
ACSM1
|
acyl-CoA synthetase medium-chain family member 1
|
2
|
|
43
|
ACSM2
|
acyl-CoA synthetase medium-chain family member 2
|
2
|
|
44
|
ACSM3
|
acyl-CoA synthetase medium-chain family member 3
|
2
|
|
45
|
ACSS2
|
acyl-CoA synthetase short-chain family member 2
|
2
|
|
46
|
ACTA1
|
actin, alpha 1, skeletal muscle
|
2
|
|
47
|
ACTA2
|
actin, alpha 2, smooth muscle, aorta
|
2
|
|
48
|
ACTC1
|
actin, alpha, cardiac muscle 1
|
2
|
|
49
|
ACTN1
|
actinin, alpha 1
|
3
|
|
50
|
ACTN3
|
actinin, alpha 3
|
2
|
|
51
|
ACVR1
|
activin A receptor, type I
|
3
|
|
52
|
ACVRL1
|
activin A receptor type II-like 1
|
2
|
|
53
|
ADA
|
adenosine deaminase
|
2
|
|
54
|
ADAM10
|
ADAM metallopeptidase domain 10
|
2
|
|
55
|
ADAM12
|
ADAM metallopeptidase domain 12 (meltrin alpha)
|
3
|
|
56
|
ADAM15
|
ADAM metallopeptidase domain 15 (metargidin)
|
2
|
|
57
|
ADAM17
|
ADAM metallopeptidase domain 17 (tumor necrosis factor, alpha, converting enzyme)
|
2
|
|
58
|
ADAM33
|
ADAM metallopeptidase domain 33
|
2
|
|
59
|
ADAM9
|
ADAM metallopeptidase domain 9 (meltrin gamma)
|
2
|
|
60
|
ADAMTS10
|
ADAM metallopeptidase with thrombospondin type 1 motif, 10
|
2
|
|
61
|
ADAMTSL1
|
ADAMTS-like 1
|
3
|
|
62
|
ADCY1
|
adenylate cyclase 1 (brain)
|
3
|
|
63
|
ADCY6
|
adenylate cyclase 6
|
2
|
|
64
|
ADD1
|
adducin 1 (alpha)
|
1
|
|
65
|
ADD2
|
adducin 2 (beta)
|
2
|
|
66
|
ADD3
|
adducin 3 (gamma)
|
2
|
|
67
|
ADH1A
|
alcohol dehydrogenase 1A (class I), alpha polypeptide
|
2
|
|
68
|
ADH1C
|
alcohol dehydrogenase 1C (class I), gamma polypeptide
|
2
|
|
69
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
1
|
|
70
|
ADIPOR1
|
adiponectin receptor 1
|
1
|
|
71
|
ADIPOR2
|
adiponectin receptor 2
|
1
|
|
72
|
ADK
|
adenosine kinase
|
3
|
|
73
|
ADM
|
adrenomedullin
|
2
|
|
74
|
ADORA1
|
adenosine A1 receptor
|
2
|
|
75
|
ADORA2A
|
adenosine A2a receptor
|
2
|
|
76
|
ADORA3
|
adenosine A3 receptor
|
2
|
|
77
|
ADRA1A
|
adrenergic, alpha-1A-, receptor
|
1
|
|
78
|
ADRA1B
|
adrenergic, alpha-1B-, receptor
|
2
|
|
79
|
ADRA1D
|
adrenergic, alpha-1D-, receptor
|
2
|
|
80
|
ADRA2A
|
adrenergic, alpha-2A-, receptor
|
1
|
|
81
|
ADRA2B
|
adrenergic, alpha-2B-, receptor
|
1
|
|
82
|
ADRA2C
|
adrenergic, alpha-2C-, receptor
|
1
|
|
83
|
ADRB1
|
adrenergic, beta-1-, receptor
|
1
|
|
84
|
ADRB2
|
adrenergic, beta-2-, receptor, surface
|
1
|
|
85
|
ADRB3
|
adrenergic, beta-3-, receptor
|
1
|
|
86
|
ADRBK1
|
adrenergic, beta, receptor kinase 1
|
1
|
|
87
|
ADRBK2
|
adrenergic, beta, receptor kinase 2
|
2
|
|
88
|
AGER
|
advanced glycosylation end product-specific receptor
|
1
|
|
89
|
AGRP
|
agouti related protein homolog (mouse)
|
2
|
|
90
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
1
|
|
91
|
AGTR1
|
angiotensin II receptor, type 1
|
1
|
|
92
|
AGTR2
|
angiotensin II receptor, type 2
|
1
|
|
93
|
AGTRAP
|
angiotensin II receptor-associated protein
|
2
|
|
94
|
AGTRL1
|
angiotensin II receptor-like 1
|
2
|
|
95
|
AHCY
|
S-adenosylhomocysteine hydrolase
|
2
|
|
96
|
AHSG
|
alpha-2-HS-glycoprotein
|
2
|
|
97
|
AIF1
|
allograft inflammatory factor 1
|
3
|
|
98
|
AIFM1
|
apoptosis-inducing factor, mitochondrion-associated, 1
|
2
|
|
99
|
AKR1B1
|
aldo-keto reductase family 1, member B1 (aldose reductase)
|
2
|
|
100
|
AKR1B10
|
aldo-keto reductase family 1, member B10 (aldose reductase)
|
2
|
|
101
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
1
|
|
102
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
1
|
|
103
|
AKT3
|
v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma)
|
2
|
|
104
|
ALB
|
albumin
|
2
|
|
105
|
ALCAM
|
activated leukocyte cell adhesion molecule
|
2
|
|
106
|
ALDH1L1
|
aldehyde dehydrogenase 1 family, member L1
|
3
|
|
107
|
ALDH2
|
aldehyde dehydrogenase 2 family (mitochondrial)
|
1
|
|
108
|
ALMS1
|
Alstrom syndrome 1
|
3
|
|
109
|
ALOX12
|
arachidonate 12-lipoxygenase
|
1
|
|
110
|
ALOX12B
|
arachidonate 12-lipoxygenase, 12R type
|
2
|
|
111
|
ALOX15
|
arachidonate 15-lipoxygenase
|
1
|
|
112
|
ALOX15B
|
arachidonate 15-lipoxygenase, type B
|
1
|
|
113
|
ALOX5
|
arachidonate 5-lipoxygenase
|
1
|
|
114
|
ALOX5AP
|
arachidonate 5-lipoxygenase-activating protein
|
1
|
|
115
|
ALOXE3
|
arachidonate lipoxygenase 3
|
2
|
|
116
|
ALX4
|
aristaless-like homeobox 4
|
2
|
|
117
|
AMBP
|
alpha-1-microglobulin/bikunin precursor
|
2
|
|
118
|
AMPD1
|
adenosine monophosphate deaminase 1 (isoform M)
|
2
|
|
119
|
ANGPT1
|
angiopoietin 1
|
2
|
|
120
|
ANGPT2
|
angiopoietin 2
|
2
|
|
121
|
ANGPT4
|
angiopoietin 4
|
2
|
|
122
|
ANGPTL1
|
angiopoietin-like 1
|
2
|
|
123
|
ANGPTL2
|
angiopoietin-like 2
|
1
|
|
124
|
ANGPTL3
|
angiopoietin-like 3
|
1
|
|
125
|
ANGPTL4
|
angiopoietin-like 4
|
1
|
|
126
|
ANK1
|
ankyrin 1, erythrocytic
|
3
|
|
127
|
ANK2
|
ankyrin 2, neuronal
|
3
|
|
128
|
ANKRD40
|
ankyrin repeat domain 40
|
2
|
|
129
|
ANKRD45
|
ankyrin repeat domain 45
|
2
|
|
130
|
ANP32A
|
acidic (leucine-rich) nuclear phosphoprotein 32 family, member A
|
2
|
|
131
|
ANXA1
|
annexin A1
|
2
|
|
132
|
ANXA2
|
annexin A2
|
2
|
|
133
|
ANXA4
|
annexin A4
|
2
|
|
134
|
ANXA5
|
annexin A5
|
2
|
|
135
|
APAF1
|
apoptotic peptidase activating factor 1
|
2
|
|
136
|
APC
|
adenomatosis polyposis coli
|
2
|
|
137
|
APC2
|
adenomatosis polyposis coli 2
|
2
|
|
138
|
APCS
|
amyloid P component, serum
|
2
|
|
139
|
APLN
|
apelin, AGTRL1 ligand
|
2
|
|
140
|
APOA1
|
apolipoprotein A-I
|
1
|
|
141
|
APOA1BP
|
apolipoprotein A-I binding protein
|
2
|
|
142
|
APOA2
|
apolipoprotein A-II
|
1
|
|
143
|
APOA4
|
apolipoprotein A-IV
|
1
|
|
144
|
APOA5
|
apolipoprotein A-V
|
1
|
|
145
|
APOB
|
apolipoprotein B (including Ag(x) antigen)
|
1
|
|
146
|
APOBEC1
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1
|
1
|
|
147
|
APOC1
|
apolipoprotein C-I
|
1
|
|
148
|
APOC2
|
apolipoprotein C-II
|
1
|
|
149
|
APOC3
|
apolipoprotein C-III
|
1
|
|
150
|
APOC4
|
apolipoprotein C-IV
|
1
|
|
151
|
APOD
|
apolipoprotein D
|
1
|
|
152
|
APOE
|
apolipoprotein E
|
1
|
|
153
|
APOF
|
apolipoprotein F
|
2
|
|
154
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I)
|
1
|
|
155
|
APOL1
|
apolipoprotein L, 1
|
1
|
|
156
|
APOM
|
apolipoprotein M
|
1
|
|
157
|
APP
|
amyloid beta (A4) precursor protein (peptidase nexin-II, Alzheimer disease)
|
1
|
|
158
|
AQP1
|
aquaporin 1 (Colton blood group)
|
2
|
|
159
|
AQP10
|
aquaporin 10
|
2
|
|
160
|
AQP3
|
aquaporin 3 (Gill blood group)
|
2
|
|
161
|
AR
|
androgen receptor (dihydrotestosterone receptor; testicular feminization; spinal and bulbar muscular atrophy; Kennedy disease)
|
1
|
|
162
|
ARAF
|
v-raf murine sarcoma 3611 viral oncogene homolog
|
2
|
|
163
|
ARG1
|
arginase, liver
|
2
|
|
164
|
ARG2
|
arginase, type II
|
2
|
|
165
|
ARHGAP4
|
Rho GTPase activating protein 4
|
2
|
|
166
|
ARHGAP5
|
Rho GTPase activating protein 5
|
2
|
|
167
|
ARHGAP6
|
Rho GTPase activating protein 6
|
2
|
|
168
|
ARHGDIB
|
Rho GDP dissociation inhibitor (GDI) beta
|
3
|
|
169
|
ARHGEF1
|
Rho guanine nucleotide exchange factor (GEF) 1
|
2
|
|
170
|
ARHGEF5
|
Rho guanine nucleotide exchange factor (GEF) 5
|
2
|
|
171
|
ARL6
|
ADP-ribosylation factor-like 6
|
2
|
|
172
|
ARMS2
|
age-related maculopathy susceptibility 2
|
2
|
|
173
|
ARNT
|
aryl hydrocarbon receptor nuclear translocator
|
1
|
|
174
|
ARNTL
|
aryl hydrocarbon receptor nuclear translocator-like
|
2
|
|
175
|
ARNTL2
|
aryl hydrocarbon receptor nuclear translocator-like 2
|
2
|
|
176
|
ARPC2
|
actin related protein 2/3 complex, subunit 2, 34kDa
|
2
|
|
177
|
ARSB
|
arylsulfatase B
|
3
|
|
178
|
ARTS-1
|
type 1 tumor necrosis factor receptor shedding aminopeptidase regulator
|
3
|
|
179
|
ARV1
|
ARV1 homolog (S. cerevisiae)
|
1
|
|
180
|
ASCC3
|
activating signal cointegrator 1 complex subunit 3
|
3
|
|
181
|
ASF1B
|
ASF1 anti-silencing function 1 homolog B (S. cerevisiae)
|
1
|
|
182
|
ASIP
|
agouti signaling protein, nonagouti homolog (mouse)
|
2
|
|
183
|
ASMT
|
acetylserotonin O-methyltransferase
|
1
|
|
184
|
ASPH
|
aspartate beta-hydroxylase
|
3
|
|
185
|
ATF1
|
activating transcription factor 1
|
2
|
|
186
|
ATF2
|
activating transcription factor 2
|
2
|
|
187
|
ATF6
|
activating transcription factor 6
|
3
|
|
188
|
ATIC
|
5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase
|
2
|
|
189
|
ATM
|
ataxia telangiectasia mutated (includes complementation groups A, C and D)
|
2
|
|
190
|
ATOH8
|
atonal homolog 8 (Drosophila)
|
2
|
|
191
|
ATP1A1
|
ATPase, Na+/K+ transporting, alpha 1 polypeptide
|
2
|
|
192
|
ATP1A2
|
ATPase, Na+/K+ transporting, alpha 2 (+) polypeptide
|
2
|
|
193
|
ATP1A3
|
ATPase, Na+/K+ transporting, alpha 3 polypeptide
|
2
|
|
194
|
ATP1B1
|
ATPase, Na+/K+ transporting, beta 1 polypeptide
|
2
|
|
195
|
ATP2A2
|
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2
|
2
|
|
196
|
ATP2B1
|
ATPase, Ca++ transporting, plasma membrane 1
|
2
|
|
197
|
ATP2B4
|
ATPase, Ca++ transporting, plasma membrane 4
|
3
|
|
198
|
ATP5B
|
ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide
|
2
|
|
199
|
ATP5J
|
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit F6
|
2
|
|
200
|
ATP6V1B1
|
ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1 (Renal tubular acidosis with deafness)
|
2
|
|
201
|
ATP6V1G2
|
ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2
|
3
|
|
202
|
ATP7A
|
ATPase, Cu++ transporting, alpha polypeptide (Menkes syndrome)
|
2
|
|
203
|
ATRX
|
alpha thalassemia/mental retardation syndrome X-linked (RAD54 homolog, S. cerevisiae)
|
1
|
|
204
|
AVP
|
arginine vasopressin (neurophysin II, antidiuretic hormone, diabetes insipidus, neurohypophyseal)
|
2
|
|
205
|
AVPR1A
|
arginine vasopressin receptor 1A
|
2
|
|
206
|
AVPR2
|
arginine vasopressin receptor 2 (nephrogenic diabetes insipidus)
|
2
|
|
207
|
AXIN1
|
axin 1
|
2
|
|
208
|
B2M
|
beta-2-microglobulin
|
2
|
|
209
|
BAD
|
BCL2-antagonist of cell death
|
1
|
|
210
|
BAG1
|
BCL2-associated athanogene
|
2
|
|
211
|
BAG3
|
BCL2-associated athanogene 3
|
2
|
|
212
|
BAG4
|
BCL2-associated athanogene 4
|
2
|
|
213
|
BAG5
|
BCL2-associated athanogene 5
|
2
|
|
214
|
BAI3
|
brain-specific angiogenesis inhibitor 3
|
3
|
|
215
|
BAK1
|
BCL2-antagonist/killer 1
|
1
|
|
216
|
BAT1
|
HLA-B associated transcript 1
|
2
|
|
217
|
BAX
|
BCL2-associated X protein
|
1
|
|
218
|
BBS1
|
Bardet-Biedl syndrome 1
|
2
|
|
219
|
BBS10
|
Bardet-Biedl syndrome 10
|
2
|
|
220
|
BBS12
|
Bardet-Biedl syndrome 12
|
3
|
|
221
|
BBS2
|
Bardet-Biedl syndrome 2
|
2
|
|
222
|
BBS4
|
Bardet-Biedl syndrome 4
|
2
|
|
223
|
BBS5
|
Bardet-Biedl syndrome 5
|
2
|
|
224
|
BBS7
|
Bardet-Biedl syndrome 7
|
3
|
|
225
|
BCAR1
|
breast cancer anti-estrogen resistance 1
|
3
|
|
226
|
BCDO2
|
beta-carotene dioxygenase 2
|
2
|
|
227
|
BCHE
|
butyrylcholinesterase
|
2
|
|
228
|
BCL2
|
B-cell CLL/lymphoma 2
|
1
|
|
229
|
BCL2A1
|
BCL2-related protein A1
|
2
|
|
230
|
BCL2L1
|
BCL2-like 1
|
1
|
|
231
|
BCL2L10
|
BCL2-like 10 (apoptosis facilitator)
|
2
|
|
232
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
3
|
|
233
|
BCL2L2
|
BCL2-like 2
|
2
|
|
234
|
BCL3
|
B-cell CLL/lymphoma 3
|
2
|
|
235
|
BCL9
|
B-cell CLL/lymphoma 9
|
2
|
|
236
|
BDK
|
bradykinin
|
2
|
|
237
|
BDKRB1
|
bradykinin receptor B1
|
3
|
|
238
|
BDKRB2
|
bradykinin receptor B2
|
2
|
|
239
|
BDNF
|
brain-derived neurotrophic factor
|
2
|
|
240
|
BHLHB2
|
basic helix-loop-helix domain containing, class B, 2
|
2
|
|
241
|
BHLHB3
|
basic helix-loop-helix domain containing, class B, 3
|
2
|
|
242
|
BHMT
|
betaine-homocysteine methyltransferase
|
2
|
|
243
|
BHMT2
|
betaine-homocysteine methyltransferase 2
|
2
|
|
244
|
BID
|
BH3 interacting domain death agonist
|
2
|
|
245
|
BIK
|
BCL2-interacting killer (apoptosis-inducing)
|
2
|
|
246
|
BIRC2
|
baculoviral IAP repeat-containing 2
|
2
|
|
247
|
BIRC3
|
baculoviral IAP repeat-containing 3
|
2
|
|
248
|
BIRC4
|
baculoviral IAP repeat-containing 4
|
2
|
|
249
|
BIRC8
|
baculoviral IAP repeat-containing 8
|
2
|
|
250
|
BLM
|
Bloom syndrome
|
2
|
|
251
|
BLR1
|
Burkitt lymphoma receptor 1, GTP binding protein (chemokine (C-X-C motif) receptor 5)
|
2
|
|
252
|
BMP10
|
bone morphogenetic protein 10
|
2
|
|
253
|
BMP2
|
bone morphogenetic protein 2
|
2
|
|
254
|
BMP4
|
bone morphogenetic protein 4
|
2
|
|
255
|
BMP5
|
bone morphogenetic protein 5
|
3
|
|
256
|
BMP6
|
bone morphogenetic protein 6
|
3
|
|
257
|
BMP7
|
bone morphogenetic protein 7 (osteogenic protein 1)
|
3
|
|
258
|
BMPR1A
|
bone morphogenetic protein receptor, type IA
|
3
|
|
259
|
BMPR1B
|
bone morphogenetic protein receptor, type IB
|
3
|
|
260
|
BMPR2
|
bone morphogenetic protein receptor, type II (serine/threonine kinase)
|
2
|
|
261
|
BOK
|
BCL2-related ovarian killer
|
2
|
|
262
|
BPI
|
bactericidal/permeability-increasing protein
|
3
|
|
263
|
BRAF
|
v-raf murine sarcoma viral oncogene homolog B1
|
3
|
|
264
|
BRCA2
|
breast cancer 2, early onset
|
2
|
|
265
|
BRIP1
|
BRCA1 interacting protein C-terminal helicase 1
|
2
|
|
266
|
BRS3
|
bombesin-like receptor 3
|
1
|
|
267
|
BSG
|
basigin (Ok blood group)
|
2
|
|
268
|
BSND
|
Bartter syndrome, infantile, with sensorineural deafness (Barttin)
|
2
|
|
269
|
BTK
|
Bruton agammaglobulinemia tyrosine kinase
|
2
|
|
270
|
BZW1
|
basic leucine zipper and W2 domains 1
|
2
|
|
271
|
C1QA
|
complement component 1, q subcomponent, A chain
|
2
|
|
272
|
C1QBP
|
complement component 1, q subcomponent binding protein
|
2
|
|
273
|
C1QTNF7
|
C1q and tumor necrosis factor related protein 7
|
3
|
|
274
|
C2
|
complement component 2
|
2
|
|
275
|
C20orf160
|
chromosome 20 open reading frame 160
|
2
|
|
276
|
C20orf27
|
chromosome 20 open reading frame 27
|
1
|
|
277
|
C21orf33
|
chromosome 21 open reading frame 33
|
3
|
|
278
|
C3
|
complement component 3
|
1
|
|
279
|
C4A
|
complement component 4A (Rodgers blood group)
|
2
|
|
280
|
C4B
|
complement component 4B (Childo blood group)
|
1
|
|
281
|
C5
|
complement component 5
|
3
|
|
282
|
C6
|
complement component 6
|
3
|
|
283
|
C7
|
complement component 7
|
3
|
|
284
|
C7orf10
|
chromosome 7 open reading frame 10
|
2
|
|
285
|
C8A
|
complement component 8, alpha polypeptide
|
2
|
|
286
|
C9
|
complement component 9
|
3
|
|
287
|
CABIN1
|
calcineurin binding protein 1
|
2
|
|
288
|
CACNA1C
|
calcium channel, voltage-dependent, L type, alpha 1C subunit
|
2
|
|
289
|
CADM1
|
cell adhesion molecule 1
|
2
|
|
290
|
CALCA
|
calcitonin/calcitonin-related polypeptide, alpha
|
2
|
|
291
|
CALCR
|
calcitonin receptor
|
3
|
|
292
|
CALCRL
|
calcitonin receptor-like
|
3
|
|
293
|
CALM1
|
calmodulin 1 (phosphorylase kinase, delta)
|
2
|
|
294
|
CALM2
|
calmodulin 2 (phosphorylase kinase, delta)
|